Michael Douglas Taylor, Director at Deciphera Pharmaceuticals, Inc. (DCPH), sold 38,000 shares at $55.80 ($2.1M) on 2021-01-04, disclosed to the SEC on 2021-01-06.
Open-market sale of $2.1M DCPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.80 | 7,689 | $429K | 20.0% |
| 2 | $55.80 | 7,689 | $429K | 20.0% |
| 3 | $56.73 | 8,517 | $483K | 22.5% |
| 4 | $56.73 | 8,517 | $483K | 22.5% |
| 5 | $57.37 | 2,794 | $160K | 7.5% |
| 6 | $57.37 | 2,794 |
| $160K |
| 7.5% |
| Total | $56.45 avg | 38,000 | $2.1M | 100% |
| Filing → |
| DCPH | SELL | 2021-03-03 | $655K | — | Filing → |
| DCPH | SELL | 2021-02-03 | $687K | — | Filing → |
| DCPH | SELL | 2020-12-03 | $2.3M | — | Filing → |